Shekoofeh Farahmandpour - Department of Biology, Faculty of Basic Sciences, Islamic Azad University, East Tehran Branch, Tehran, Iran.
Nastaran Dehghani - Department of Biology, Faculty of Basic Sciences, Islamic Azad University, East Tehran Branch, Tehran, Iran.
Asra Khalkhalizadeh - Department of Biology, Faculty of Basic Sciences, Islamic Azad University, East Tehran Branch, Tehran, Iran
Paniz Hajihossein - Department of Biology, Faculty of Basic Sciences, Islamic Azad University, East Tehran Branch, Tehran, Iran.
Armin Nikdehqan - Department of Biology, Faculty of Basic Sciences, Islamic Azad University, East Tehran Branch, Tehran, Iran.

There were more than thirty-eight million HIV infections worldwide. Combination antiretroviral therapy (cART) has progressed to the point where invisible viral loads are now feasible, and HIV carriers frequently lead almost everyday lives with considerably greater average life expectancies than in the past. However, there is still no cure for the disease. Even though the ailment usually advances to a chronic state, an individual's unique course of progression may differ significantly from the average and manifest distinctively for each patient. This diversity begs whether a typical treatment strategy is appropriate for a patient..

HIV infections, Personalized Medicine, Antiviral inhibitors, Gene-editing approach